Statement 5: the first line of treatment for children with idiopathic short stature (ISS) and low serum insulin-like growth factor-I (IGF-I) should be IGF-I

Pediatr Endocrinol Rev. 2008 Apr:5 Suppl 3:853-6.

Author

Philippe Backeljauw¹

Affiliation

¹ Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Division of Endocrinology, University of Cincinnati College of Medicine Cincinnati, Ohio, USA.

PMID: 18438329

No abstract available

Publication types

Review

MeSH terms

Body Height*
Child
Evidence-Based Medicine
Growth Disorders / drug therapy*
Humans
Insulin-Like Growth Factor I / deficiency*
Insulin-Like Growth Factor I / metabolism
Insulin-Like Growth Factor I / therapeutic use*
Laron Syndrome / drug therapy*

Substances

Insulin-Like Growth Factor I